Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06860867 · ClinicalTrials.gov registry record · NA
PerQdisc Traditional Feasibility Trial.
A NA study of Discogenic Low Back Pain, sponsored by Spinal Stabilization Technologies.
- Recruiting
- Registry status
- NA
- Development phase
- 5
- Enrollment target
- 8
- Study locations
NCT06860867 is a NA study of Discogenic Low Back Pain that is actively recruiting participants, run by Spinal Stabilization Technologies. The registered enrollment target is 5 participants. The trial reports 8 study locations across 5 states.
The verdict
NCT06860867, a NA study of Discogenic Low Back Pain, is actively recruiting participants, sponsored by Spinal Stabilization Technologies.
- RECRUITING
- Registry status
- NA
- Development phase
- 5 participants
- Enrollment target
- 8
- Study locations
Study Summary
This is a traditional feasibility study (TFS) study to evaluate the safety and effectiveness of the PerQdisc. The study is prospective, multicenter, and open label. After a screening period, qualified participants will be enrolled and treated with the PerQdisc. Patients will not be blinded to their treatment. Participants will then complete the safety follow-up period.
Conditions Studied
Interventions
- DEVICE PerQdisc
Study Locations (8)
Arizona
- Hope Research Institute - Glendale
- The CORE Institute - Phoenix
- HOPE Research Institute - Phoenix
- HonorHealth Research & Innovation Institute - Scottsdale
Idaho
- Axis Spine Center - Coeur d'Alene
Indiana
- Indiana Spine Group - Carmel
Louisiana
- Spine Institute of Louisiana - Shreveport
Oklahoma
- SonoSpine - Oklahoma City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2025-01-10 |
| Est. Completion | 2030-03-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06860867
The ClinicalTrials.gov registry entry for NCT06860867 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 5 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Spinal Stabilization Technologies, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Discogenic Low Back Pain appearing as the primary indexed condition, and to 1 intervention - of which PerQdisc is the first listed.
NCT06860867 reports 8 study locations spanning 5 distinct geographic areas - top geographies include Arizona, Idaho, Indiana.
Frequently Asked Questions
What is clinical trial NCT06860867 about?
NCT06860867 is a clinical study titled "PerQdisc Traditional Feasibility Trial.". This is a traditional feasibility study (TFS) study to evaluate the safety and effectiveness of the PerQdisc. The study is prospective, multicenter, and open label. After a screening period, qualified participants will be enrolled and treated with the PerQdisc. Patients will not be blinded to their...
What is the current status of trial NCT06860867?
This trial is currently recruiting. It is a NA study. The enrollment target is 5 participants. The study started on 2025-01-10. Estimated completion is 2030-03-31.
What conditions does trial NCT06860867 study?
This clinical trial studies the following conditions: Discogenic Low Back Pain.
What interventions are being tested in trial NCT06860867?
The interventions under investigation include: PerQdisc (DEVICE).
Who is sponsoring clinical trial NCT06860867?
This trial is sponsored by Spinal Stabilization Technologies, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06860867 being conducted?
This trial has 8 study locations across Arizona, Idaho, Indiana, Louisiana, Oklahoma. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Discogenic Low Back Pain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.